FrancophonIA/ELRC3.0 huggingface dataset:
English: Similarly, recent treatment with hepatotoxic or haematotoxic medicinal products (e.g. methotrexate) may result in increased side effects; therefore, the initiation of leflunomide treatment has to carefully be considered regarding these benefit/risk aspects and closer monitoring is recommended in the initial
Croatian: Isto tako, nedavno provedeno liječenje hepatotoksičnim ili hematotoksičnim lijekovima (npr. metotreksatom) može dovesti do pojave većeg broja nuspojava.
English: Neoplasms benign, malignant and unspecified (incl cysts and polyps) The risk of malignancy, particularly lymphoproliferative disorders, is increased with use of some
Croatian: Dobroćudne, zloćudne i nespecificirane novotvorine (uključujući ciste i polipe)
English: EU/1/11/675/002 100 film-coated tablets
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE GOTOVOG LIJEKA U PROMET EU/1/11/675/001 30 filmom obloženih tableta EU/1/11/675/002 100 filmom obloženih tableta
English: - Diarrhoea.
Croatian: Aktivni metabolit
English: In a study with radiolabelled
Croatian: Zbog ekstenzivnog vezanja za bjelančevine
English: Skin and subcutaneous tissue disorders Common:
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva
English: - An increase of certain enzymes in the blood (creatine phosphokinase).
Croatian: - bol, oticanje i osjetljivost, najčešće u šakama ili ručnim zglobovima; - porast koncentracije određenih enzima u krvi (kreatin fosfokinaze);
English: If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Croatian: U slučaju bilo kakvih nejasnoća ili pitanja u vezi s primjenom ovog lijeka, obratite se svom liječniku,
English: cutaneous lupus erythematosus, pustular psoriasis or worsening psoriasis Musculoskeletal and connective tissue disorders
Croatian: psorijaza (novonastala psorijaza ili pogoršanje psorijaze).
English: mild allergic reactions severe anaphylactic/anaphylactoid reactions, vasculitis, including cutaneous hypokalaemia, hyperlipidemia, hypophosphataemia paraesthesia, headache, dizziness, peripheral neuropathy
Croatian: Vrlo rijetko: teške anafilaktične/anafilaktoidne reakcije, vaskulitis, uključujući kožni nekrotizirajući
English: Respiratory, thoracic and mediastinal disorders interstitial lung disease (including interstitial pneumonitis), which may be fatal diarrhoea, nausea, vomiting, oral mucosal disorders (e.g., aphthous stomatitis,
Croatian: leukopenija, parestezija, glavobolja, omaglica, proljev, mučnina, povraćanje, poremećaji sluznice usne šupljine (npr. aftozni stomatitis, ulceracije u ustima), bol u trbuhu, pojačani gubitak kose, ekcem, osip (uključujući makulopapulozni osip), svrbež, suha koža, tenosinovitis, povećanje CPK, anoreksija,
English: leucopenia (leucocytes > 2 G/l)
Croatian: 0,02 mg/l (vidjeti dio 4.6.).
English: Danmark
Croatian: Mađarska
English: Entresto tablets are taken twice a day.
Croatian: Tablete lijeka Entresto uzimaju se dva puta na dan.
English: The doctor may choose lower doses for certain patients.
Croatian: Liječnik može propisati niže doze određenim bolesnicima.
English: In general, patients were monitored for about 27 months, during which they took the medicine for about 24 months on average.
Croatian: Bolesnike se u pravilu nadziralo otprilike 27 mjeseci tijekom kojih su u prosjeku uzimali lijek otprilike 24 mjeseca.
English: The full EPAR and risk management plan summary for Entresto can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR kao i sažetak plana upravljanja rizikom za lijek Entresto nalaze se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The recommended starting dose is one tablet of Entresto 49 mg / 51 mg twice a day and the dose is then doubled after 2 to 4 weeks to 97 mg / 103 mg twice a day.
Croatian: Preporučena početna doza je jedna tableta lijeka Entresto od 49 mg / 51 mg dva puta na dan, a doza se zatim nakon dva do četiri tjedna udvostručuje na 97 mg / 103 mg dva puta na dan.
English: Other information about Entresto
Croatian: Ostale informacije o lijeku Entresto
English: Entresto sacubitril / valsartan
Croatian: Entresto sakubitril/valsartan
English: Why is Entresto approved?
Croatian: Zašto je Entresto odobren?
English: What measures are being taken to ensure the safe and effective use of Entresto?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Entresto?
English: It is not intended to provide practical advice on how to use Entresto.
Croatian: Svrha sažetka nije davati praktične savjete o korištenju lijeka Entresto.
English: Entresto is available as tablets (24 mg sacubitril / 26 mg valsartan, 49 mg sacubitril / 51 mg valsartan, and 97 mg sacubitril / 103 mg valsartan).
Croatian: Entresto je dostupan u obliku tablete (24 mg sakubitrila / 26 mg valsartana, 49 mg sakubitrila / 51 mg valsartana i 97 mg sakubitrila / 103 mg valsartana).
English: What is Entresto and what is it used for?
Croatian: Što je Entresto i za što se koristi?
English: The study was stopped early because there was compelling evidence that Entresto was more effective than enalapril.
Croatian: Ispitivanje je prekinuto u ranoj fazi zbog uvjerljivih dokaza da je Entresto djelotvorniji od enalaprila.
English: This is a summary of the European public assessment report (EPAR) for Entresto.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Entresto.
English: Entresto can only be obtained with a prescription.
Croatian: Entresto se izdaje samo na liječnički recept.
English: A risk management plan has been developed to ensure that Entresto is used as safely as possible.
Croatian: Pripremljen je plan upravljanja rizikom kako bi se osigurala što sigurnija primjena lijeka Entresto.
English: It must not be taken by patients who have suffered angioedema, those who have severe liver disease or by women who are pregnant.
Croatian: Ne smiju ga uzimati bolesnici koji su imali angioedem, oni koji boluju od teške bolesti jetre i trudnice.
English: Valsartan is an ‘angiotensin-II-receptor antagonist', which means that it blocks the action of a hormone called angiotensin II.
Croatian: Valsartan je „antagonist receptora angiotenzina II”, što znači da sprečava djelovanje hormona angiotenzin II.
English: Entresto must not be taken with medicines known as ACE inhibitors (which are used to treat heart failure and high blood pressure).
Croatian: Entresto se ne smije uzimati s lijekovima poznatima kao ACE inhibitori (koji se koriste za liječenje zatajenja srca i visokog krvnog tlaka).
English: What are the risks associated with Entresto?
Croatian: Koji su rizici povezani s lijekom Entresto?
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Entresto's benefits are greater than its risks and recommended that it be approved for use in the EU.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) pri Agenciji odlučio je da koristi od lijeka Entresto nadmašuju s njim povezane rizike te je preporučio njegovo odobrenje za korištenje u Europskoj uniji.
English: A potentially severe side effect, angioedema (rapid swelling of deeper skin tissues as well as the tissues around the throat, causing breathing difficulty), can occur uncommonly (affecting fewer than 1 in 100 people).
Croatian: Moguća ozbiljna nuspojava, odnosno angioedem (brzo oticanje dubljih kožnih tkiva i tkiva oko grla, što dovodi do otežanog disanja), rijetko se pojavljuje (javlja se u manje od 1 na 100 osoba).
English: Sacubitril blocks the breakdown of natriuretic peptides produced in the body.
Croatian: Sakubitril sprečava raspadanje natriuretskih peptida koji se proizvode u tijelu.
English: The effects of angiotensin II can be harmful in patients with heart failure.
Croatian: Učinci hormona angiotenzin II mogu biti štetni za bolesnike sa zatajenjem srca.
English: It is used in adults with long-term heart failure who have symptoms of the disease.
Croatian: Upotrebljava se u odraslih osoba s kroničnim zatajenjem srca koji imaju simptome te bolesti.
English: The two active substances in Entresto, sacubitril and valsartan, work in different ways.
Croatian: Dvije djelatne tvari u lijeku Entresto, sakubitril i valsartan, djeluju na različite načine.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Entresto, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana, u sažetku opisa svojstava lijeka kao i u uputi o lijeku za lijek Entresto nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: Entresto is a heart medicine that contains the active substances sacubitril and valsartan.
Croatian: Entresto je lijek za srce koji sadrži djelatne tvari sakubitril i valsartan.
English: In the group treated with Entresto, 21.8% (914 of 4,187) patients either died as a result of heart and circulation problems or were admitted to hospital with heart failure compared to 26.5% (1,117 of 4,212) patients treated with enalapril.
Croatian: Za razliku od 26,5 % bolesnika (1 117 od 4 212) liječenih enalaprilom, u skupini bolesnika liječenih lijekom Entresto 21,8 % bolesnika (914 od 4 187) umrlo je od srčanih i problema i problema s cirkulacijom ili je primljeno u bolnicu zbog zatajenja srca.
English: The most common side effects with Entresto (which may affect more than 1 in 10 people) are high blood potassium levels, low blood pressure and the kidneys working less well.
Croatian: Najčešće nuspojave lijeka Entresto (mogu se javiti u više od 1 na 10 osoba) su visoka razina kalija u krvi, niski krvni tlak i lošiji rad bubrega.
English: Natriuretic peptides also reduce blood pressure and protect the heart from developing fibrosis (scar tissues) that occurs in heart failure.
Croatian: Natriuretski peptidi također smanjuju krvni tlak i štite srce od nastanka fibroze (ožiljkasto tkivo) koja se javlja pri zatajenju srca.
English: Valsartan, one of the active substances in the medicine, is well established for the treatment of high blood pressure and heart failure; its side effects are well known.
Croatian: Poznato je da se valsartan, jedna od djelatnih tvari lijeka, koristi za liječenje visokog krvnog tlaka i zatajenja srca; dobro su poznate i njegove nuspojave.
English: Heart failure is the inability of the heart to pump enough blood around the body.
Croatian: Zatajenje srca stanje je pri kojemu srce ne može istisnuti dovoljnu količinu krvi kroz tijelo.
English: By blocking the receptors to which angiotensin II normally attaches, valsartan stops the hormone's harmful effects on the heart and it also reduces blood pressure by allowing blood vessels to widen.
Croatian: Valsartan blokiranjem receptora na koje se angiotenzin II inače vezuje zaustavlja štetne učinke koje taj hormon ima na srce te također smanjuje krvni tlak omogućivanjem širenja krvnih žila.
English: Natriuretic peptides cause sodium and water to pass into the urine thereby reducing the strain on the heart.
Croatian: Natriuretski peptidi uzrokuju ispuštanje natrija i vode u urin, čime se smanjuje pritisak na srce.
English: Patients in the study had long-term heart failure with symptoms of the disease and reduced ejection fraction (the proportion of blood leaving the heart).
Croatian: U ispitivanju su sudjelovali bolesnici s kroničnim zatajenjem srca sa simptomima te bolesti i smanjenom ejekcijskom frakcijom (količina krvi koju istiskuje srce).
English: Entresto's serious side effects in the main study were similar to those of enalapril, which is already authorised for use in heart failure.
Croatian: Ozbiljne nuspojave lijeka Entresto otkrivene u glavnom ispitivanju slične su onima enalaprila, koji je već odobren za primjenu pri zatajenju srca.
English: For further information, see the summary of product characteristic (also part of the EPAR).
Croatian: Za dodatne informacije vidjeti sažetak opisa svojstava lijeka (također dio EPAR-a).
English: For more information about treatment with Entresto, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Entresto pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svom liječniku ili ljekarniku.
English: The main study found that Entresto reduced deaths from heart and circulation problems or hospital admissions for heart failure.
Croatian: Glavno je ispitivanje pokazalo da Entresto smanjuje broj smrtnih slučajeva uzrokovanih srčanim problemima i problemima s cirkulacijom te broj prijama u bolnicu zbog zatajenja srca.
English: How is Entresto used?
Croatian: Kako se Entresto koristi?
English: What benefits of Entresto have been shown in studies?
Croatian: Koje su koristi lijeka Entresto utvrđene u ispitivanjima?
English: For practical information about using Entresto, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o korištenju lijeka Entresto pročitajte u uputi o lijeku, odnosno obratite se svom liječniku ili ljekarniku.
English: In the main study, Entresto was compared to enalapril, another medicine used for heart failure.
Croatian: U glavnom je ispitivanju Entresto uspoređen s enalaprilom, drugim lijekom za zatajenje srca.
English: How does Entresto work?
Croatian: Kako djeluje Entresto?
English: For the full list of all side effects reported with Entresto, see the package leaflet.
Croatian: Potpuni popis nuspojava zabilježenih pri primjeni lijeka Entresto potražite u uputi o lijeku.
English: All these reactions disappear within 6 days.
Croatian: Sve ove reakcije nestaju unutar 6 dana.
English: Date of first authorisation: 07/11/2014.
Croatian: Datum prvog odobrenja: 07/11/2014.
English: Protect from direct sunlight.
Croatian: Zaštiti od direktnog sunčevog svjetla.
English: ATCvet code: QI09AL08.
Croatian: ATCvet kod: QI09AL08
English: If such reactions occur, appropriate treatment is recommended.
Croatian: Ukoliko se pojave takve reakcije preporuča se odgovarajuće liječenje.
English: In laboratory studies and field trials:
Croatian: U laboratorijskim i terenskim ispitivanjima:
English: This veterinary medicinal product contains mineral oil.
Croatian: Ovaj veterinarsko-medicinski proizvod sadrži mineralno ulje.
English: Avoid introduction of contamination.
Croatian: Izbjegavati mogućnost kontaminacije.
English: Needle length and diameter should be adapted to the age of the animal.
Croatian: Duljinu i promjer igle treba prilagoditi starosti životinje.
English: Light mineral oil
Croatian: Svijetlo mineralno ulje
English: A-3500, Krems
Croatian: A-3500, Krems Austria
English: Aluminium (as hydroxide)
Croatian: Aluminij (hidroksid)
English: 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Croatian: 4.10 Predoziranje (simptomi, hitni postupci, antidoti), ako je nužno Nema dostupnih podataka.
English: The excipients (including adjuvants) listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product.
Croatian: Pomoćne tvari (uključujući adjuvanse) navedene u dijelu 6.1 SPC su ili dozvoljene tvari za koje je u tablici 1, Dodatka Uredbe Komisije (EU) br. 37/2010 navedeno da određivanje MRL nije nužno, ili se smatra da se na njih ne primjenjuju odredbe Uredbe (EZ) br. 470/2009 kada se primjenjuju u tim veterinarsko-medicinskim proizvodima.
English: 2 ml contains:
Croatian: 2 ml sadrži:
English: 1 Antigenic units as determined in the in vitro potency test (ELISA).
Croatian: 1 Jedinice antigena određene in vitro testom potencije (ELISA).
English: Cardboard box
Croatian: Kartonska kutija
English: Shelf life of the veterinary medical product as packaged for sale: 2 years.
Croatian: Rok valjanosti veterinarsko-medicinskog proizvoda kad je zapakiran za prodaju: 2 godine.
English: Vaccinate pigs by the intramuscular route in the neck.
Croatian: Svinje cijepiti intramuskularno u vrat.
English: EU/2/14/175/001 (20 ml) EU/2/14/175/002 (50 ml) EU/2/14/175/003 (100 ml) EU/2/14/175/004 (200 ml) EU/2/14/175/005 (500 ml) EU/2/14/175/006 (10x20 ml) EU/2/14/175/007 (10x50 ml) EU/2/14/175/008 (10x100 ml) EU/2/14/175/009 (10x200 ml) EU/2/14/175/010 (10x500 ml)
Croatian: EU/2/14/175/005 (500 ml) EU/2/14/175/006 (10x20 ml) EU/2/14/175/007 (10x50 ml) EU/2/14/175/008 (10x100 ml) EU/2/14/175/009 (10x200 ml)
English: EXP {month/year} Once broached use within 8 hours.
Croatian: EXP {mjesec/godina} Jednom otvoreno, upotrijebiti u roku od 8 sati.
English: Intervet UK Limited Walton Manor Walton,
Croatian: Walton Manor Walton,
English: Intramuscular use.
Croatian: Intramuskularna upotreba.
English: If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.
Croatian: Ukoliko zamijetite bilo koju nuspojavu čak i onu koja nije navedena u ovoj uputi o VMP ili mislite da je veterinarsko-medicinski proizvod nedjelotvoran, molimo obavijestite svog veterinara.
English: Incompatibilities: Do not mix with any other veterinary medicinal product.
Croatian: Inkompatibilnosti: Ne miješati s bilo kojim drugim veterinarsko-medicinskim proizvodom.
English: The active substances being a principle of biological origin intended to produce active immunity is not within the scope of Regulation (EC) No 470/2009.
Croatian: Djelatna tvar se sastoje od tvari biološkog podrijetla, namijenjena je za stvaranje aktivne imunosti, na nju se ne primjenjuju odredbe Uredbe (EZ) br. 470/2009.
English: Safety and efficacy data are available which demonstrate that this vaccine can be given with Porcilis PRRS at the same time at separate sites from 3 weeks of age.
Croatian: Dostupni su podaci o neškodljivosti i učinkovitosti koji ukazuju da se ovo cjepivo može davati s Porcilis PRRS istovremeno na različitim mjestima aplikacije od 3. tjedna starosti.
English: PET (polyethylene terephthalate) vials of 20, 50, 100, 200 or 500 ml, closed with nitrile rubber stoppers and sealed with aluminium caps.
Croatian: PET (polietilen tereftalat) bočice od 20, 50, 100, 200 i 500 ml zatvorenih s nitril gumenim čepom i zapečaćene s aluminijskom kapicom.
English: Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
Croatian: Bilo koji neupotrebljeni veterinarsko-medicinski proizvod ili otpadni materijali dobiveni primjenom tih veterinarsko-medicinskih proizvoda trebaju se odlagati u skladu s lokalnim propisima.
English: Cardboard box with 1 or 10 vials of 20, 50, 100, 200 or 500 ml.
Croatian: Kartonska kutija s 1 ili 10 bočica od 20, 50, 100, 200 i 500 ml.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Croatian: Učestalost nuspojava je određena sukladno sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojavu za vrijeme trajanja tretmana) - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja) - rijetke (više od 1 ali manje od 10 životinja na 10.000 tretiranih životinja) - vrlo rijetke (manje od 1 životinje na 10.000 tretiranih životinja, uključujući izolirane slučajeve).
English: Ethyl alcohol Glycerol
Croatian: Etilni alkohol Glicerol
English: Pharmacotherapeutic group: Immunologicals for Suidae, inactivated viral and inactivated bacterial vaccines for pigs.
Croatian: Farmakoterapijska grupa: imunološki pripravci za svinje, inaktivirana virusna i inaktivirana bakterijska cjepiva za svinje.
English: The product literature of Porcilis PRRS should be consulted.
Croatian: Potrebno je pregledati podatke o Porcilis PRRS.
English: If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you.
Croatian: Ukoliko ste nehotično injicirani ovim proizvodom, potražite hitnu medicinsku pomoć čak ako je injicirana vrlo mala količina i sa sobom ponesite uputu o VMP.
English: Name and address of the manufacturers of the biological active substances
Croatian: Naziv i adresa proizvođača biološki djelatnih tvari
English: These reactions disappear within 12 days after the first vaccination of the two dose vaccination schedule and within 3 days after completion of either the single or the two dose vaccination schedule.
Croatian: Ove reakcije nestaju unutar 12 dana nakon prvog cijepljenja kod dvokratnog plana cijepljenja i unutar 3 dana nakon obavljenog jednokratnog ili dvokratnog plana cijepljenja.
English: Accidental injection/self-injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given.
Croatian: Nehotična injekcija/samo injiciranje može prouzročiti jaku bol i oticanje, naročito ako se injicira u zglob prsta, a u rijetkim slučajevima može rezultirati gubitkom zahvaćenog prsta ukoliko nije pružena hitna medicinska pomoć.
English: Before using the vaccine allow it to reach room temperature (15 °C - 25 °C) and shake well before use.
Croatian: Prije primjene cjepivo treba doseći sobnu temperaturu (15 °C-25 °C) te dobro protresti.
English: No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the product mentioned above.
Croatian: Ne postoje dostupni podaci o neškodljivosti i učinkovitosti ovog cjepiva kada se upotrebljava s drugim veterinarsko-medicinskim proizvodom osim s ranije navedenim proizvodom.
English: Sodium chloride Water for injections
Croatian: Natrij klorid Voda za injekcije
English: Date of last renewal: dd/mm/yyyyy
Croatian: Datum zadnjeg produženja: dd/mm/gggg.
English: Adjuvants:
Croatian: Adjuvans:
English: Pigs for fattening.
Croatian: Svinje za tov.
English: In post marketing experience (with single dose vaccination):
Croatian: Iskustva nakon stavljanja u promet (kod jednokratnog cijepljenja) :
English: Anaphylactic-type reactions, which may be life-threatening, can occur in very rare cases.
Croatian: Mogu se pojaviti anafilaktičke reakcije koje mogu biti opasne po život u vrlo rijetkim slučajevima.
English: Two injections each of 1 ml in pigs starting at 3 days of age with an interval of at least 18 days.
Croatian: Dvije injekcije od koje svaka po 1 ml za svinje stare tri dana te nakon najmanje 18 dana.
English: M. hyopneumoniae inac.
Croatian: M. hyopneumoniae:
English: A transient increase in body temperature very commonly occurs on the day of vaccination (mean ±1 °C, in individual pigs up to 2 °C).
Croatian: Na dan cijepljenja vrlo često se pojavljuje prolazno povećanje tjelesne temperature ( prosječno ± 1°C, kod pojedinih svinja do 2°C).
English: A hypersensitivity-like reaction may be observed in rare cases after the first vaccination of the two dose vaccination schedule.
Croatian: Može biti uočena reakcija preosjetljivosti u rijetkim slučajevima nakon prvog cijepljenja kod dvokratnog plana cijepljenja.
English: Pigs for fattening
Croatian: Svinje za tov
English: Emulsion for injection.
Croatian: Emulzija za injekciju.
English: Intervet International GmbH Osterather Strasse 1a 50739 Köln
Croatian: Intervet International GmbH Osterather Strasse 1a